These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18645035)
1. Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules. Kapelyukh Y; Paine MJ; Maréchal JD; Sutcliffe MJ; Wolf CR; Roberts GC Drug Metab Dispos; 2008 Oct; 36(10):2136-44. PubMed ID: 18645035 [TBL] [Abstract][Full Text] [Related]
2. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4. Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114 [TBL] [Abstract][Full Text] [Related]
3. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672 [TBL] [Abstract][Full Text] [Related]
4. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Stresser DM; Blanchard AP; Turner SD; Erve JC; Dandeneau AA; Miller VP; Crespi CL Drug Metab Dispos; 2000 Dec; 28(12):1440-8. PubMed ID: 11095581 [TBL] [Abstract][Full Text] [Related]
5. Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency. Polic V; Sevrioukova IF; Auclair K Arch Biochem Biophys; 2018 Sep; 653():90-96. PubMed ID: 29958895 [TBL] [Abstract][Full Text] [Related]
7. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations. Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the interaction between human P450 3A4 and B. megaterium reductase via engineered loops. Castrignanò S; D'Avino S; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):116-125. PubMed ID: 28734977 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4. Sevrioukova IF; Poulos TL Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486 [TBL] [Abstract][Full Text] [Related]
10. Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data. Paragas EM; Wang Z; Korzekwa K; Nagar S Drug Metab Dispos; 2021 Dec; 49(12):1100-1108. PubMed ID: 34503953 [TBL] [Abstract][Full Text] [Related]
11. Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation. Polic V; Auclair K Bioconjug Chem; 2017 Apr; 28(4):885-889. PubMed ID: 28339191 [TBL] [Abstract][Full Text] [Related]
12. Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism. Kenworthy KE; Clarke SE; Andrews J; Houston JB Drug Metab Dispos; 2001 Dec; 29(12):1644-51. PubMed ID: 11717184 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel substrates for human cytochrome P450 2J2. Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256 [TBL] [Abstract][Full Text] [Related]
14. Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction. Fahmi OA; Hurst S; Plowchalk D; Cook J; Guo F; Youdim K; Dickins M; Phipps A; Darekar A; Hyland R; Obach RS Drug Metab Dispos; 2009 Aug; 37(8):1658-66. PubMed ID: 19406954 [TBL] [Abstract][Full Text] [Related]
15. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding. Sevrioukova IF J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132 [TBL] [Abstract][Full Text] [Related]
16. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
17. Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5. Okada Y; Murayama N; Yanagida C; Shimizu M; Guengerich FP; Yamazaki H Drug Metab Dispos; 2009 Jan; 37(1):18-23. PubMed ID: 18948377 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail. Lee E; Shon JC; Liu KH Biopharm Drug Dispos; 2016 Sep; 37(6):366-72. PubMed ID: 27323294 [TBL] [Abstract][Full Text] [Related]
19. Metabolic stereoselectivity of cytochrome P450 3A4 towards deoxypodophyllotoxin: In silico predictions and experimental validation. Julsing MK; Vasilev NP; Schneidman-Duhovny D; Muntendam R; Woerdenbag HJ; Quax WJ; Wolfson HJ; Ionkova I; Kayser O Eur J Med Chem; 2008 Jun; 43(6):1171-9. PubMed ID: 17998150 [TBL] [Abstract][Full Text] [Related]
20. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Ohno Y; Hisaka A; Suzuki H Clin Pharmacokinet; 2007; 46(8):681-96. PubMed ID: 17655375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]